Science Explorer Back to mapMap
Discussion
Researcher · Bayer (Germany) · Germany

Oliver von Ahsen

Oliver von Ahsen publishes mostly in Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications and Cancer Cells and Metastasis.

ORCID 0000-0003-1906-9078 OpenAlex
World rank
#281,985
of 7,710,434 ranked researchers
Rank in Germany
#14,181
of 364,343
Works
152
Citations
3.6k
Citations per work
23.8
h-index
27
i10-index 41Top 19% in Molecular Biology
Oliver von Ahsen

What does Oliver von Ahsen research?

Oliver von Ahsen's work is mostly in Medicine (35%), Biochemistry, Genetics and Molecular Biology (34%), Immunology and Microbiology (5%).

Life Sciences: 60 works · 39.8% of their workBiochemistry, Genetics and Molecular Biology: 52 works · 34.4% of their workMolecular Biology: 44 works · 29.0% of their workCancer Research: 8 works · 5.4% of their workImmunology and Microbiology: 8 works · 5.4% of their workImmunology: 8 works · 5.4% of their workHealth Sciences: 54 works · 35.2% of their workMedicine: 54 works · 35.2% of their workOncology: 24 works · 15.8% of their workRadiology, Nuclear Medicine and Imaging: 20 works · 13.1% of their workPulmonary and Respiratory Medicine: 10 works · 6.3% of their workEverything else: 38 works · 25.0% of their workTHEIR WORKOliver von Ahsen152works
Life Sciences40%Health Sciences35%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology5234.4%
    2. Immunology and Microbiology85.4%
    1. Medicine5435.2%
  3. Everything else3825.0%
  1. 1Molecular Biology29% of their works
  2. 2Oncology16% of their works
  3. 3Radiology, Nuclear Medicine and Imaging13% of their works
  4. 4Pulmonary and Respiratory Medicine6% of their works
  5. 5Cancer Research5% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Oliver von Ahsen's research?

The keywords of their largest research topics: Targeted Therapy, Fc Receptors, Therapeutic Antibodies, PET Imaging, Radiopharmaceuticals, Cancer Therapy, Androgen Receptor and Cancer Stem Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Targeted Therapy222 topics
  2. Fc Receptors151 topic
  3. Therapeutic Antibodies151 topic
  4. PET Imaging141 topic
  5. Radiopharmaceuticals141 topic
  6. Cancer Therapy112 topics
  7. Androgen Receptor101 topic
  8. Cancer Stem Cells101 topic
  9. Prostate Cancer101 topic
  10. Tumor Metastasis101 topic
  11. Breast Cancer81 topic
  12. Cancer Genomics81 topic
  13. HER281 topic
  14. Mutational Signatures81 topic
  15. Molecular Chaperones61 topic
  16. Protein Folding61 topic
  17. Cell Division51 topic
  18. Microtubules51 topic

Where does Oliver von Ahsen work?

Oliver von Ahsen's main affiliation in the publication record is Bayer (Germany), Germany.

How many publications and citations does Oliver von Ahsen have?

OpenAlex counts 152 works and 3,615 citations for Oliver von Ahsen, an h-index of 27, ranking #281,985 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Oliver von Ahsen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.